These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 11774836)
41. Life-threatening reaction after first ever dose of abacavir in an HIV-1-infected patient. de la Rosa R; Harris M; Uyeda L; Goodison K; Keown P; Montaner JS AIDS; 2004 Feb; 18(3):578-9. PubMed ID: 15090818 [No Abstract] [Full Text] [Related]
42. Advances in HIV therapeutics: news from the 4th International AIDS Society Conference. Boyle BA; Elion R; Cohen CJ; DeJesus E; Hawkins T; Moyle GJ AIDS Read; 2007 Oct; 17(10):484-90. PubMed ID: 17990370 [No Abstract] [Full Text] [Related]
43. Abacavir hypersensitivity. Vandekerckhove L; Blot S; Vogelaers D N Engl J Med; 2008 Jun; 358(23):2514-5; author reply 2515-6. PubMed ID: 18525052 [No Abstract] [Full Text] [Related]
44. Neuropsychiatric reaction induced by abacavir. Colebunders R; Hilbrands R; De Roo A; Pelgrom J Am J Med; 2002 Nov; 113(7):616. PubMed ID: 12459415 [No Abstract] [Full Text] [Related]
45. Hypersensitivity syndrome associated with efavirenz therapy. Bossi P; Colin D; Bricaire F; Caumes E Clin Infect Dis; 2000 Jan; 30(1):227-8. PubMed ID: 10619772 [No Abstract] [Full Text] [Related]
46. Sweet's syndrome following abacavir therapy. Del Giudice P; Vandenbos F; Perrin C; Bernard E; Marq L; Dellamonica P J Am Acad Dermatol; 2004 Sep; 51(3):474-5. PubMed ID: 15337997 [No Abstract] [Full Text] [Related]
47. [Safety in routine clinical practice. Hypersensitivity can be managed]. MMW Fortschr Med; 2000; 142(3 Suppl):22-3. PubMed ID: 10893956 [No Abstract] [Full Text] [Related]
48. Are disulfiram-like reactions associated with abacavir-containing antiretroviral regimens in clinical practice? Barber TJ; Marett B; Waldron S; Portsmouth S; Mackie NE; Weston R; Winston A AIDS; 2007 Aug; 21(13):1823-4. PubMed ID: 17690585 [TBL] [Abstract][Full Text] [Related]
49. Hypersensitivity reactions due to abacavir. Newsline People AIDS Coalit N Y; 1998 Feb; ():35-6. PubMed ID: 11367446 [TBL] [Abstract][Full Text] [Related]
50. Abacavir warning: certain respiratory symptoms can indicate hypersensitivity reaction. AIDS Treat News; 2000 Feb; (No 337):7-8. PubMed ID: 11367210 [TBL] [Abstract][Full Text] [Related]
52. Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. Phillips EJ; Sullivan JR; Knowles SR; Shear NH AIDS; 2002 Nov; 16(16):2223-5. PubMed ID: 12409746 [No Abstract] [Full Text] [Related]
53. 'Fine tuning' HIV therapy. Report on the 9th Conference on Retroviruses and Opportunistic Infections. Linde M Posit Living; 2002; 11(3):8-9, 16, 44. PubMed ID: 12035759 [No Abstract] [Full Text] [Related]
54. Severe abacavir hypersensitivity reaction in a patient tested HLA-B*5701 negative. Bonta PI; Vermeulen JN; Speelman P; Prins JM AIDS; 2008 Jul; 22(12):1522-3. PubMed ID: 18614879 [No Abstract] [Full Text] [Related]
55. Understanding drug hypersensitivity: what to look for when prescribing abacavir. Hetherington S AIDS Read; 2001 Dec; 11(12):620-2. PubMed ID: 11806176 [TBL] [Abstract][Full Text] [Related]
56. HLA-B*5701 genetic screening prior to abacavir prescription in Georgia. Dvali N; Chkhartishvili N; Sharvadze L; Karchava M; Tsertsvadze T Georgian Med News; 2010 Dec; (189):16-20. PubMed ID: 21252404 [TBL] [Abstract][Full Text] [Related]
57. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Chui CK; Brumme ZL; Brumme CJ; Yip B; Phillips EJ; Montaner JS; Harrigan PR Clin Infect Dis; 2007 Jun; 44(11):1503-8. PubMed ID: 17479950 [TBL] [Abstract][Full Text] [Related]